Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
Oncoimmunology
|
October 15, 2021
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma
Merve Hasanov, Denái R Milton, William H Sharfman, et al.
Cancers
|
August 23, 2020
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma
Merve Hasanov, Matthew J Rioth, Kari Kendra, et al.
The Journal of Clinical Investigation
|
December 9, 2014
Follicular helper T cell signature in type 1 diabetes
Rupert Kenefeck, Chun Jing Wang, Tauseef Kapadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2017
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina V Long, Zeynep Eroglu, Jeffrey Infante, et al.
The American Journal of Gastroenterology
|
June 12, 2023
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors
Marcel Yibirin, Khalis Mustafayev, Jeff Hosry, et al.
European Heart Journal. Digital Health
|
January 30, 2023
Daily angina documentation versus subsequent recall: development of a symptom smartphone app
Alexandra N Nowbar, James P Howard, Matthew J Shun-Shin, et al.
Journal for Immunotherapy of Cancer
|
May 22, 2021
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
Chantal Saberian, Rodabe N Amaria, Amer M Najjar, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2019
Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2018
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
Oncoimmunology
|
October 15, 2021
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma
Merve Hasanov, Denái R Milton, William H Sharfman, et al.
Cancers
|
August 23, 2020
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma
Merve Hasanov, Matthew J Rioth, Kari Kendra, et al.
The Journal of Clinical Investigation
|
December 9, 2014
Follicular helper T cell signature in type 1 diabetes
Rupert Kenefeck, Chun Jing Wang, Tauseef Kapadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2017
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina V Long, Zeynep Eroglu, Jeffrey Infante, et al.
The American Journal of Gastroenterology
|
June 12, 2023
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors
Marcel Yibirin, Khalis Mustafayev, Jeff Hosry, et al.
European Heart Journal. Digital Health
|
January 30, 2023
Daily angina documentation versus subsequent recall: development of a symptom smartphone app
Alexandra N Nowbar, James P Howard, Matthew J Shun-Shin, et al.
Journal for Immunotherapy of Cancer
|
May 22, 2021
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
Chantal Saberian, Rodabe N Amaria, Amer M Najjar, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2019
Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2018
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Page
of 8